News Opinion Editor's Corner TCT 2025 What’s Going to Be Hot at TCT 2025 Michael O'Riordan October 09, 2025
News Conference News SCCT 2024 Should Coronary Calcium Always Be Noted on Noncardiac CT Reports? Todd Neale July 24, 2024
News Conference News EuroPCR 2024 OCT-Based Strategy Outperforms Angiography in Calcified Lesions: CALIPSO Caitlin E. Cox May 16, 2024
News Conference News ACC 2023 Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III Shelley Wood March 04, 2023
News Conference News TCT 2022 New Faces, New Formats, New Tech: What to Expect From TCT 2022 Shelley Wood September 07, 2022
News Conference News ACC 2022 PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI Todd Neale April 03, 2022
News Daily News Vasospasm Linked to Higher Atherosclerotic Risk in Patients With ANOCA Yael L. Maxwell January 27, 2022
News Conference News TCT 2020 Trickier Patients, Fewer Adverse Events in High-risk PCI: Impella PROTECT III Registry Caitlin E. Cox October 18, 2020
News Conference News TCT 2019 Intravascular Lithotripsy Shows Good Safety at 30 Days: DISRUPT CAD II Yael L. Maxwell October 08, 2019
News Conference News TCT 2019 New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing Todd Neale September 28, 2019
News Conference News EuroPCR 2019 Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements Shelley Wood May 16, 2019
News Daily News Vulnerable Plaque Components Seen on IVUS Not Linked With MACE, Two New Studies Show Michael O'Riordan October 17, 2018
News Daily News Serial CTA Shines a Light on Statin Effects in Subclinical CAD Yael L. Maxwell June 15, 2018
News Conference News SCCT 2017 Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See? Yael L. Maxwell July 10, 2017
News Daily News Lowering LDL With Statins and Other Selected Agents Should Be Focus of CVD Risk Reduction, Analysis Implies Michael O'Riordan September 27, 2016
News Daily News CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study Michael O'Riordan September 22, 2016
News Conference News ESC 2016 Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION Michael O'Riordan August 30, 2016
News Conference News ESC 2016 Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say Michael O'Riordan August 27, 2016
News Daily News Amount of Calcium, Not Calcium Progression, May Be Best for Gauging CV Risk Michael H. Wilson July 07, 2016